{"id":123288,"name":"U.S. HEREDITARY ANGIOEDEMA ASSOCIATION","slug":"us-hereditary-angioedema-association","state":"HI","country":"United States of America","description":"Non-profit patient advocacy org. dedicated to providing wide-ranging services to patients","totalSpending":360000,"filings":36,"yearlySpending":[{"year":2018,"income":40000},{"year":2019,"income":40000},{"year":2020,"income":50000},{"year":2021,"income":40000},{"year":2022,"income":40000},{"year":2023,"income":60000},{"year":2024,"income":50000},{"year":2025,"income":40000}],"issues":[{"code":"HCR","display":"Health Issues"},{"code":"BUD","display":"Budget/Appropriations"}],"firms":["HEALTH AND MEDICINE COUNSEL, LLC"],"lobbyists":["DALE DIRKS","DANE CHRISTIANSEN","PHILIP GOGLAS","KATHERINE CRUZ","JOSHUA FEIN"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE"],"sampleDescriptions":["Patients' Access to Treatments Act \n\nFollow on Biologics \n\nAccess to Marketplace Insurance \n\nPFDDI @ FDA\n\nHealthcare Reform, Patient Protections\n\nCost Sharing issues for life sustaining medicine","FY17 & FY18 L-HHS Appropriations Bills \n\nFY17 & FY18 DoD Appropriations Bills","Patients' Access to Treatments Act \n\nFollow on Biologics \n\nAccess to Marketplace Insurance \n\nPFDDI @ FDA\n\nHealthcare Reform, Patient Protections\n\nCost Sharing issues for life sustaining medicine","FY19 L-HHS Appropriations Bills \n\nFY19 DoD Appropriations Bills","Patients' Access to Treatments Act \n\nFollow on Biologics \n\nAccess to Marketplace Insurance \n\nPFDDI @ FDA\n\nHealthcare Reform, Patient Protections\n\nCost Sharing issues for life sustaining medicine"]}